Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Report
Real-time Quote. Real-time Tradegate - 12/12 11:33:02 am
105.466 EUR   +0.30%
12:56a Monsanto offers cash to U.S. farmers who use controversial chemic..
12/08 EU regulators to warn Bayer about Monsanto bid
12/07 BAYER : New Bayer transparency website launched
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Bayer : Brazil agency says Bayer-Monsanto tie-up can hurt competition, urges conditions

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/04/2017 | 08:41pm CET
FILE PHOTO: Monsanto logo is displayed on a screen where the stock is traded on the floor of the NYSE

A unit of Brazil's competition regulator Cade has said Bayer AG's (>> Bayer) proposed takeover of Monsanto Co. (>> Monsanto) could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows.

A unit of Brazil's competition regulator Cade has said Bayer AG's (>> Bayer) proposed takeover of Monsanto Co. (>> Monsanto) could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows.

The Bayer-Monsanto transaction, announced in September 2016, would create the world's largest integrated pesticides and seeds company.

The Cade unit said that anticipated merger-related efficiencies were insufficient to mitigate its competition concerns, according to the document dated Oct. 3.

It recommended what it termed as "structural solutions" as a condition for final approval the deal, which will be in the hands of Cade's seven-member tribunal.

Cade has 330 days to make a final decision since it began its review of the deal on April 24, a spokesman for the agency said. However, he added it may announce a ruling as early as Dec. 20.

The Cade unit said solutions included creating or strengthening another player to compete in the markets for soy and cotton seeds and in the sphere of biotech development.

But the unit has not engaged in an in-depth discussion with Bayer and Monsanto related to its suggested "remedies," the document said.

In an emailed statement to Reuters, Bayer said the unit's opinion is non-binding and does not mean the transaction will be blocked.

Hugh Grant, Monsanto's chief executive officer, said concerns expressed by Brazil's regulator are a normal step in the review process.

Brazil is Monsanto's biggest market outside of the United States.

In its second-quarter results, Bayer said sales of its crop science division tumbled more than 15 percent primarily because of its business in Brazil, an indication of the country's weight as a market for seed technology, insecticides and herbicides.

Deal opponents have asked Cade to block it or force divestments including Monsanto's Intacta RR2 IPRO soy seed technology and Bayer's glufosinate ammonium herbicides.

Last week, Monsanto's chief executive officer for South America, Rodrigo Santos, told Reuters the company was set on keeping rights to Intacta.

Cotton farmers against the transaction assert the merged company would control 14 out of 15 genetically modified cotton seed technologies available in Brazil.

If Cade orders asset disposals from the companies, authorities must see to it that the buyer is a relevant player in the biotech, seed production and crop defence segments, said attorney Rachel Mendonça, a partner at Mendonça e Nogueira Advogados.

Her law firm is representing three industry groups opposing the deal.

(Reporting by Ana Mano; editing by Alexander Smith and W Simon)

By Ana Mano

Stocks treated in this article : Monsanto, Bayer
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
12:56a Monsanto offers cash to U.S. farmers who use controversial chemical
12/08 EU regulators to warn Bayer about Monsanto bid
12/08 BAYER : Preventive Maintenance & service solution on existing Bayer/Medrad and A..
12/08 BAYER : J-- Preventive Maintenance & service solution on existing Bayer/Medrad a..
12/08 'Right steps' point to a healthier China
12/07 BAYER : Research Conducted at Bayer Has Provided New Information about Atrial Fi..
12/07 BAYER : Findings from Bayer Has Provided New Data on Liver Cancer (Exposure-resp..
12/07 BAYER : New Findings from Bayer in Antibiotics Provides New Insights (Physiologi..
12/07 BAYER : New Bayer transparency website launched
12/07 BAYER : Many disease-causing pathogens that are transferable from pets to humans..
More news
News from SeekingAlpha
12/11 Buy Celgene And Regeneron On The Dips As Insiders Are Buying
12/08 BLOOMBERG : Bayer to face EU objections to Monsanto deal in coming days
12/07 COBAS ASSET MANAGEMENT : Comments On Third Quarter 2017
12/06 You Get A Dilution! You Get A Dilution! What About CRISPR Therapeutics?
12/05 3 THINGS IN BIOTECH YOU SHOULD LEARN : December 5, 2017
Financials (€)
Sales 2017 35 698 M
EBIT 2017 7 647 M
Net income 2017 6 050 M
Debt 2017 8 890 M
Yield 2017 2,50%
P/E ratio 2017 13,85
P/E ratio 2018 18,12
EV / Sales 2017 2,68x
EV / Sales 2018 2,44x
Capitalization 86 954 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 121 €
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER5.62%102 387
JOHNSON & JOHNSON21.53%379 175
NOVARTIS12.15%218 773
PFIZER9.30%215 837
ROCHE HOLDING LTD.3.40%209 423
MERCK AND COMPANY-6.96%153 659